Literature DB >> 20425090

The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy.

Satish K S Kumar1, Amita Gorur, Christoph Schaudinn, Charles F Shuler, J William Costerton, Parish P Sedghizadeh.   

Abstract

Microbial biofilms have been observed and described in bone specimens of patients with bisphosphonate (BP)-associated osteonecrosis of the jaw (BONJ) and investigators are more recently suggesting that this condition essentially represents an osteomyelitis of the jaw clinically, with greater susceptibility in some patients on BP therapy. This article explains the role of microbial biofilms in BONJ and also discusses associated factors in the disease pathogenesis, which include BP effects on bone remodeling, anti-angiogenesis, matrix necrosis, microcracks, soft tissue toxicity, and inflammation and wound healing. Recent findings suggest a key role for microbial biofilms in the pathogenesis of BONJ; this has important therapeutic implications because biofilm organisms represent a clinical target for prevention and treatment efforts aimed at reducing the significant morbidity and costs associated with this condition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425090     DOI: 10.1007/s11914-010-0008-1

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  52 in total

Review 1.  Bacterial biofilms: an emerging link to disease pathogenesis.

Authors:  Matthew R Parsek; Pradeep K Singh
Journal:  Annu Rev Microbiol       Date:  2003       Impact factor: 15.500

Review 2.  Osteonecrosis of the jaw: who gets it, and why?

Authors:  Ian R Reid
Journal:  Bone       Date:  2008-10-07       Impact factor: 4.398

Review 3.  Is aseptic loosening truly aseptic?

Authors:  Carl L Nelson; Alex C McLaren; Sandra G McLaren; Jeffrey W Johnson; Mark S Smeltzer
Journal:  Clin Orthop Relat Res       Date:  2005-08       Impact factor: 4.176

4.  Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis.

Authors:  Torsten Hansen; Martin Kunkel; Achim Weber; C James Kirkpatrick
Journal:  J Oral Pathol Med       Date:  2006-03       Impact factor: 4.253

5.  Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation.

Authors:  Steven G Waguespack; Siu L Hui; Linda A Dimeglio; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2006-12-12       Impact factor: 5.958

6.  Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study.

Authors:  Philipp Stockmann; Fabian M Hinkmann; Michael M Lell; Matthias Fenner; Eleftherios Vairaktaris; Friedrich-Wilhelm Neukam; Emeka Nkenke
Journal:  Clin Oral Investig       Date:  2009-06-10       Impact factor: 3.573

7.  Mandibular necrosis in beagle dogs treated with bisphosphonates.

Authors:  D B Burr; M R Allen
Journal:  Orthod Craniofac Res       Date:  2009-08       Impact factor: 1.826

Review 8.  Bisphosphonates in multiple myeloma.

Authors:  B Djulbegovic; K Wheatley; J Ross; O Clark; G Bos; H Goldschmidt; F Cremer; M Alsina; A Glasmacher
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 9.  Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?

Authors:  Ingo J Diel; Ignac Fogelman; Bilal Al-Nawas; Bodo Hoffmeister; Cesar Migliorati; Joseph Gligorov; Kalervo Väänänen; Liisa Pylkkänen; Martin Pecherstorfer; Matti S Aapro
Journal:  Crit Rev Oncol Hematol       Date:  2007-09-12       Impact factor: 6.312

10.  Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.

Authors:  C I Ripamonti; M Maniezzo; T Campa; E Fagnoni; C Brunelli; G Saibene; C Bareggi; L Ascani; E Cislaghi
Journal:  Ann Oncol       Date:  2008-07-22       Impact factor: 32.976

View more
  23 in total

Review 1.  Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review.

Authors:  Cesar A Migliorati; Joel B Epstein; Elliot Abt; James R Berenson
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

Review 2.  Use of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies.

Authors:  Si-Huei Lee; Rai-Chi Chan; Shy-Shin Chang; Yin-Ling Tan; Kai-Hsiang Chang; Matthew C Lee; Huai-En Chang; Chien-Chang Lee
Journal:  Support Care Cancer       Date:  2013-11-08       Impact factor: 3.603

3.  Antibiotic effects on bacterial profile in osteonecrosis of the jaw.

Authors:  X Ji; S Pushalkar; Y Li; R Glickman; K Fleisher; D Saxena
Journal:  Oral Dis       Date:  2011-08-29       Impact factor: 3.511

4.  Prevalence and risk factors of medication-related osteonecrosis of the jaw in osteoporotic and breast cancer patients: a cross-sectional study.

Authors:  Ana Laura Soares; Sérgio Simon; Luiz Henrique Gebrim; Afonso Celso P Nazário; Marise Lazaretti-Castro
Journal:  Support Care Cancer       Date:  2019-08-29       Impact factor: 3.603

Review 5.  The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw.

Authors:  C Jacobsen; W Zemann; J A Obwegeser; K W Grätz; P Metzler
Journal:  Oral Maxillofac Surg       Date:  2012-12-28

Review 6.  Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw.

Authors:  J Chang; A E Hakam; L K McCauley
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

7.  Metagenomic investigation of microbes and viruses in patients with jaw osteonecrosis associated with bisphosphonate therapy.

Authors:  Parish P Sedghizadeh; Shibu Yooseph; Douglas W Fadrosh; Lisa Zeigler-Allen; Mathangi Thiagarajan; Hamid Salek; Farid Farahnik; Shannon J Williamson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-12

8.  Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.

Authors:  Drake W Williams; Cindy Lee; Terresa Kim; Hideo Yagita; Hongkun Wu; Sil Park; Paul Yang; Honghu Liu; Songtao Shi; Ki-Hyuk Shin; Mo K Kang; No-Hee Park; Reuben H Kim
Journal:  Am J Pathol       Date:  2014-08-28       Impact factor: 4.307

9.  Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw.

Authors:  Jin-Woo Kim; Maria Erika A Landayan; Ju-Young Lee; Jacquiline Czar I Tatad; Sun-Jong Kim; Myung-Rae Kim; In-Ho Cha
Journal:  Clin Oral Investig       Date:  2016-01-22       Impact factor: 3.573

Review 10.  Pathophysiology of Osteonecrosis of the Jaws.

Authors:  Tara Aghaloo; Renna Hazboun; Sotirios Tetradis
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2015-09-26       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.